Royce & Associates LP decreased its stake in AMN Healthcare Services Inc (NYSE:AMN) by 31.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 733,444 shares of the company’s stock after selling 341,240 shares during the period. Royce & Associates LP owned about 1.54% of AMN Healthcare Services worth $33,518,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of AMN. California Public Employees Retirement System bought a new position in shares of AMN Healthcare Services during the 1st quarter valued at $503,000. Credit Suisse AG bought a new position in shares of AMN Healthcare Services during the 1st quarter valued at $1,088,000. Bank of Montreal Can bought a new position in shares of AMN Healthcare Services during the 2nd quarter valued at $105,000. Creative Planning bought a new position in shares of AMN Healthcare Services during the 2nd quarter valued at $155,000. Finally, Aperio Group LLC grew its holdings in shares of AMN Healthcare Services by 20.5% during the 2nd quarter. Aperio Group LLC now owns 37,390 shares of the company’s stock valued at $1,460,000 after purchasing an additional 6,350 shares during the last quarter.

In other AMN Healthcare Services news, Director Andrew M. Stern sold 10,000 shares of the stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $42.89, for a total transaction of $428,900.00. Following the completion of the sale, the director now owns 6,668 shares of the company’s stock, valued at approximately $285,990.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Brian M. Scott sold 20,000 shares of the stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $50.19, for a total transaction of $1,003,800.00. Following the sale, the chief financial officer now directly owns 56,916 shares of the company’s stock, valued at approximately $2,856,614.04. The disclosure for this sale can be found here. Insiders have sold a total of 142,927 shares of company stock valued at $6,426,230 in the last three months. 2.49% of the stock is currently owned by corporate insiders.

Shares of AMN Healthcare Services Inc (NYSE:AMN) opened at $49.00 on Friday. The firm has a market cap of $2,345.62, a price-to-earnings ratio of 19.25 and a beta of 0.47. The company has a current ratio of 1.81, a quick ratio of 1.81 and a debt-to-equity ratio of 0.60. AMN Healthcare Services Inc has a 12-month low of $33.61 and a 12-month high of $51.75.

AMN Healthcare Services (NYSE:AMN) last announced its quarterly earnings results on Thursday, November 2nd. The company reported $0.63 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.03. The business had revenue of $494.41 million during the quarter, compared to analysts’ expectations of $493.89 million. AMN Healthcare Services had a net margin of 5.99% and a return on equity of 25.55%. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.62 EPS. equities research analysts expect that AMN Healthcare Services Inc will post 2.56 earnings per share for the current fiscal year.

Several equities analysts recently commented on AMN shares. ValuEngine raised shares of AMN Healthcare Services from a “hold” rating to a “buy” rating in a report on Saturday, August 12th. KeyCorp reaffirmed a “buy” rating and set a $56.00 target price on shares of AMN Healthcare Services in a report on Thursday. BMO Capital Markets reaffirmed a “buy” rating and set a $48.00 target price (up previously from $47.00) on shares of AMN Healthcare Services in a report on Sunday, November 12th. Benchmark reaffirmed a “buy” rating and set a $52.00 target price (up previously from $47.00) on shares of AMN Healthcare Services in a report on Wednesday, October 25th. Finally, Zacks Investment Research raised shares of AMN Healthcare Services from a “hold” rating to a “buy” rating and set a $51.00 target price on the stock in a report on Tuesday, October 3rd. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $49.13.

TRADEMARK VIOLATION NOTICE: “AMN Healthcare Services Inc (AMN) Shares Sold by Royce & Associates LP” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.thecerbatgem.com/2017/12/08/amn-healthcare-services-inc-amn-shares-sold-by-royce-associates-lp.html.

AMN Healthcare Services Company Profile

AMN Healthcare Services, Inc provides healthcare workforce solutions and staffing services at acute and sub-acute care hospitals and other healthcare facilities throughout the United States. The Company’s segments include nurse and allied solutions, locum tenens solutions and other workforce solutions.

Want to see what other hedge funds are holding AMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMN Healthcare Services Inc (NYSE:AMN).

Institutional Ownership by Quarter for AMN Healthcare Services (NYSE:AMN)

Receive News & Stock Ratings for AMN Healthcare Services Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMN Healthcare Services Inc and related stocks with our FREE daily email newsletter.